Content area

Abstract

Protein prenylation is a post-translational lipid modification that governs a variety of important cellular signaling pathways, including those regulating synaptic functions and cognition in the nervous system. Two enzymes, farnesyltransferase (FT) and geranylgeranyltransferase type I (GGT), are essential for the prenylation process. Genetic reduction of FT or GGT ameliorates neuropathology but only FT haplodeficiency rescues cognitive function in transgenic mice of Alzheimer’s disease. A follow-up study showed that systemic or forebrain neuron-specific deficiency of GGT leads to synaptic and cognitive deficits under physiological conditions. Whether FT plays different roles in shaping neuronal functions and cognition remains elusive. This study shows that in contrast to the detrimental effects of GGT reduction, systemic haplodeficiency of FT has little to no impact on hippocampal synaptic plasticity and cognition. However, forebrain neuron-specific FT deletion also leads to reduced synaptic plasticity, memory retention, and hippocampal dendritic spine density. Furthermore, a novel prenylomic analysis identifies distinct pools of prenylated proteins that are affected in the brain of forebrain neuron-specific FT and GGT knockout mice, respectively. Taken together, this study uncovers that physiological levels of FT and GGT in neurons are essential for normal synaptic/cognitive functions and that the prenylation status of specific signaling molecules regulates neuronal functions.

Details

Title
Neuronal Protein Farnesylation Regulates Hippocampal Synaptic Plasticity and Cognitive Function
Author
Qu Wenhui 1   VIAFID ORCID Logo  ; Suazo, Kiall F 2   VIAFID ORCID Logo  ; Liu, Wenfeng 3   VIAFID ORCID Logo  ; Cheng, Shaowu 3 ; Jeong, Angela 3 ; Hottman, David 3 ; Li-Lian, Yuan 4 ; Distefano, Mark D 2   VIAFID ORCID Logo  ; Li, Ling 5   VIAFID ORCID Logo 

 University of Minnesota, Graduate Program in Neuroscience, Minneapolis, USA (GRID:grid.17635.36) (ISNI:0000000419368657) 
 University of Minnesota, Department of Chemistry, Minneapolis, USA (GRID:grid.17635.36) (ISNI:0000000419368657) 
 University of Minnesota, Department of Experimental and Clinical Pharmacology, Minneapolis, USA (GRID:grid.17635.36) (ISNI:0000000419368657) 
 Des Moines University, Department of Physiology and Pharmacology, Des Moines, USA (GRID:grid.255049.f) (ISNI:0000 0001 2110 718X) 
 University of Minnesota, Graduate Program in Neuroscience, Minneapolis, USA (GRID:grid.17635.36) (ISNI:0000000419368657); University of Minnesota, Department of Experimental and Clinical Pharmacology, Minneapolis, USA (GRID:grid.17635.36) (ISNI:0000000419368657); University of Minnesota, Graduate Program in Pharmacology, Minneapolis, USA (GRID:grid.17635.36) (ISNI:0000000419368657) 
Pages
1128-1144
Publication year
2021
Publication date
Mar 2021
Publisher
Springer Nature B.V.
ISSN
08937648
e-ISSN
15591182
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2488176376
Copyright
© Springer Science+Business Media, LLC, part of Springer Nature 2020.